Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations: Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil

Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil

Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil

Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil

View all 54 locations

View Trial Details

Active, Not Recruiting

Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

NCT04863885

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Histotripsy (HistoSonics®) for Liver Tumours

NCT06579833

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The University of Hong Kong Hong Kong

View Trial Details

Active, Not Recruiting

Infusion System for Hepatic Cancer

NCT04684862

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

NCT06129084

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations: Arthur J.E Child Comprehensive Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

BC Cancer Agency Vancouver, British Columbia, Canada

London Health Sciences Centre London, Ontario, Canada

View Trial Details

Active, Not Recruiting

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05340270

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +13 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Active, Not Recruiting

A Prospective Observational Study on Efficacy of TARE for Early Stage HCC

NCT07278102

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

NCT05320692

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

NCT05363631

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: University of Iowa Hospitals & Clinics Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

NCT04238637

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: University Hospital Dresden Dresden, Germany

Clinic Essen Center Essen, Germany

University Hospital Essen Essen, Germany

University Hospital Halle Halle, Germany

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions